chd

chd

1. Brachial artery EDD was damaged in patients with CHD, and it may indirectly reflect the degree of coronary artery lesions.

CHD患者常存在肱动脉EDD受损,肱动脉EDD可间接反映冠脉病变程度。

2. In the CHD group, the fibrinogenic level in plasma was correlative to the number of the strictured coronary arteries.

CHD患者的血浆纤维蛋白原含量与冠脉狭窄支数有密切关系。

3. The serum VEGF and IL-18 levels in the CHD patients were higher than those in the controls(t=9.094,6.638;P<0.01).

CHD病人血清VEGF与IL-18水平显著高于对照组(t=9.094、6.638,P<0.01);

4. CK-DSE diagnosing CHD is safe, accurate and reliable.

CK -DSE诊断CHD安全、准确、客观

5. The sensitivity, specificity ,accuracy and positive and negative predictive values of CK-DSE diagnosing CHD were 92 6%,78 3%, 86%,83 3% and 94 2%.

CK -DSE诊断CHD的敏感性、特异性、准确性、阳性预测值和阴性预测值分别为 92 6%、78 3%、86%、83 3%和 94 2%。

6. ECG,TMT,TTM and Holter are common and important non-i nvasive electrocardiographic methods for CHD.

ECG、TMT、TTM、Holter是诊断CHD的常用且重要的无创检查方法。

7. The correlations of GMPT-GBPI and that of GBPI-UCG in CHD group were obviously lower than in non-CHD group (r: 0.640 vs. 0.912, 0.670 vs. 0.892).

GMPT-GBPI之间和GBPI-UCG之间的相关性在冠心病组明显低于非冠心病组(r值分别为:0.640对0.912和0.670对0.892)。

8. M allelic frequency is significantly higher in CHD group than in control group (P<0.05).

M等位基因在冠心病组的分布频率明显高于对照组(P<0.05)；

9. The level of sPLA2 is higher in CHD patients,which is positively correlated with CAS.

sPLA2在冠心病患者中明显增高,且与CAS呈正相关;

10. The prolonged S-T segment was common in CHD, and next was HHD, PHD and hypocalcemia.

ST段延长主要见于冠心病 ,其次见于高心病、肺心病及低血钙等

11. Compared with CC genotype,subjects with TT genotype has decreasing risk of CHD(Adjusted OR=0.49,95%CI:0.25-0.98).

TT基因型者患冠心病的危险性降低(校正OR=0.49,95%CI:0.25~0.98);

12. In CHD patients, Fg of patients with TVD and occllusion lesion were larger.

三支、闭塞病变的冠心病组血浆纤维蛋白原水平较高；

13. How to prevent and cure CHD and ventricular premature beat (VBP) with Chinese medicine (CM) has become a popular focus.

中医药防治冠心病室性早搏也成了研究焦点。

14. Therefore,combining the UCG and the ECG would rarsing the value in diagnosing CHD.

二者配合使用，可以取长补短，是诊断老年CHD的较可靠的无创检测手段。

15. Subgroup analyses showed that both fruits and vegetables had a significant protective effect on CHD.

亚变量分析表明水果和蔬菜均对CHD有显著的保护作用。

16. Congenital heart disease (CHD) is heart disease in the newborn, and includes structural defects, congenital arrythmias, and cardiomyopathies.

什么是'先天性心脏病-心脏病目前的出生时'?

17. CHD patients with J wave are poor prognosis.

伴有J波的冠心病患者预后不良。

18. Risk factors of CHD were not significant between the two groups (P>0.05).

但CHD危险因素两组间差异无统计学意义(P>0.05)。

19. Sec. 101.81 Health claims: Soluble fiber from certain foods and risk of coronary heart disease (CHD).

低饱和脂肪和低胆固醇而且还有来自某些食物的可溶性纤维与冠状动脉心脏病风险的关系。

20. Congenital heart disease(CHD) is one of the most common birth defects and harms to health of the infants severely.

先天性心脏病是新生儿先天缺陷中最常见的疾病之一。

21. The highest frequency of CHD was VSD(20%), then ASD(18%).

先心病发病率最高是室间隔缺损(VSD)22%,其次是房间隔缺损(ASD)18%。

22. There were 36 cases of incident nonfatal MI, 27 cases of fatal CHD, and 53 cases of angina pectoris.

其中36人出现了非致死性MI，27人发生致死性CHD，53人患有心绞痛。

23. Coronary heart disease(CHD) and depression are always coexistent and affect each other.

冠心病与抑郁症是两种相互影响的疾病,且两种疾病常合并存在。

24. Relations between the CHD and the inflammation has been generally accepted.

冠心病与炎症的关系已得到公认,高血压与炎症的关系也愈加受到重视。

25. The levels of APN in patients with CHD were significantly lower than those in control group (P < 0.01).

冠心病各组APN水平低于对照组(P<0.01),冠心病3组间APN水平差异亦有统计学意义(P<0.01);

26. Coronary heart disease (CHD) with angina pectoris in 55 patients (M 39, F 16;age 58 1 7a)were treated po with amlodipine 5 mg, qd for 4 wk.

冠心病心绞痛55例(男性39例,女性16例;年龄58±7a)采用单项药物氨氯地平5mg, po, qd共治疗4wk。

27. Analysis of ECG and A Comparison of Serum Trace ElementsSelenium,Magnesium,Zinc and Molybdenum Contents in CHD Patients.

冠心病患者心电图分析及血清硒镁锌钼含量比较

28. There is correlation between the platelet inhibition rate and main heart and brain vascular events in CHD patients during 6 months after stenting.

冠心病患者支架置入术后的血小板抑制率与6个月的主要心脑血管事件相关。

29. The relative factors of CRP and prediction of major adverse cardiac events (MACE) for coronary disease (CHD).

冠心病病人CRP的影响因素及对主要不良心脏事件(MACE)的预测。

30. Serum concentration of adiponectin in CHD patients was significantly lower than that in the control group, and there were sex differences (P<0.05).

冠心病病人血清脂联素的浓度显著低于对照组,且男女存在性别差异(P<0.05)。

31. The frequency of the L-selectin gene 213P allele in CHD patients was significantly higher than that in the control group (77.59% vs 69.35%, P=0.006).

冠心病组213P等位基因频率明显高于对照组(77.59%vs69.35%,P=0.006)。

32. The IMT,crouse score and plaque incidence were significantly higher in CHD groups than in controls.

冠心病组IMT、斑块积分及斑块发生率明显高于对照组,差异有显著性意义(P<0.01);

33. The serum leptin concentration in the CHD group was significantly higher than those in the control group(P<0.01).

冠心病组血清Leptin水平显著高于对照组(P<0.01);

34. Clinical Observation on Angina Pectoris in CHD Treated with Guanxin Paste.

冠心膏治疗冠心病心绞痛的临床观察

35. Coronary angiography(CAG) is the gold standard in diagnosing CHD,which can not detect microcirculatory pathological changes of coronary artery.

冠脉造影作为诊断冠心病的金标准,并不能探查冠状动脉微循环的病变情况。

36. Severe CHD was defined as tetralogy of Fallot, truncus arteriosus, transposition complexes, endocardial cushion defects, and univentricular heart.

单心室心脏、心内膜垫缺损、复杂性大动脉转位、动脉干、法洛四联症等确定为严重CHD。

37. What is the relationship between LDL-C and CHD risk?

和冠心病风险之间存在何种关系？

38. Matrix metalloproteinases participate in the development of Coronary Heart Disease (CHD),and play an important role in restenosis.

基质金属蛋白酶参与冠心病的发生发展过程,并在术后再狭窄中具有重要作用。

39. The ratio of VSD and ASD is 27% and 18% in CHD children,respectively.

婴幼儿先心病中VSD和ASD 各占27%、18%。

40. The infants with CHD who were born from year 1992 to 1995 in our hospital were followed up for three years.

对1992至1995年出生的先心病患儿,随访3年。

41. Spironolactone with Betaloc is effective and safety mean for treating chronic heart failure induced by CHD and HHD.

小剂量螺内酯联用倍他乐克配合常规治疗用于冠心病及高血压性心脏病慢性心力衰竭的疗效显著、安全、价廉。

42. Site of strictures:LHD in 37.6%,LHD+RND+CND in 17.4%,RHD in 9.6%,CHD in 14.7%,and LHD+RND in 11.5%.

左肝管＋右肝管11.5%。 胆管下端狭窄与松弛者分别为23.6%与48.8%。

43. Treadmill Electrocardiogram Test (TET) is one of the most popular methods in the evaluation and diagnosis of Coronary Heart Disease (CHD).

平板运动试验是临床上最常用的评价心肌缺血和协助诊断冠心病的检查方法之一。

44. She was stck with polios a gery young chd, leaving her with a twisted foot and leg.

幼年时，她患了小儿麻痹，腿和脚都变形了。

45. The sensitivity and specificity of negative propranolol test on CHD were 92.3%and 90.6%respectively.

心得安试验阴性对CAD诊断的敏感性92.3%，特异性90.6%。

46. Sensitivity,specificity and accuracy of bicycle exercise test for diagnosing CHD were 73.5%(50/68),82.9%(68/82) and 78.7%(118/150),respectively.

心电图踏车运动试验诊断冠心病的敏感性73.5%(50/68),特异性82.9%(68/82),准确性78.7%(118/150)。

47. We discovered that those who had one or two alcoholic drinks a day had a 32 percent lower risk of dying from CHD than abstainers did.

我们发现，每天喝一两杯酒的人，死于CHD的机率比不喝酒的人低了32%。

48. Four main mechanisms of the action of aryloxyphenoxypropionate (APP)and cyclohexanedione(CHD)herbicides have been reported.

报道了两类除草剂芳氧苯氧丙酸酯（APP）和环己二酮（CHD）的四种主要的除草作用机制。

49. To study the relationship between paraoxonasel(PON1) and coronary heart disease(CHD) of polygenic disease.

探讨对氧磷酶1(PON1)与多基因病冠心病(CHD)之间的相关性。

50. Compared with CC genotype,individuals with CT+TT have decreased risk of CHD(OR=0.45,95%CI:0.23-0.87).

携带CT+TT基因型的研究对象患冠心病的危险性降低(OR=0.45,95%CI:0.23~0.87);

51. Coronary heart disease (CHD) and depression are always coexistent and affect each other.

摘要冠心病与抑郁症是两种相互影响的疾病，且两种疾病常合并存在。

52. Coronary artery disease, a major cause of myocardial ischemia and hypoxia, is also called Coronary Heart Disease (CHD).

摘要冠状动脉心脏病，简称冠心病，是造成国人心肌缺血氧的最常见原因，其最常见的是心绞痛，主要的病机是心脏的气血亏虚。

53. Objective To discuss the approaches of diagnosis and treatment of children congenital heart diseases (CHD) with tracheal stenosis.

摘要目的探讨儿童先天性心脏病合并气管狭窄的诊治。

54. Objective To study the treatment role of vitrectomy in eyes with combined rhegmatogenous retinal detachment (RRD) and choroidal detachment (CHD).

摘要目的研究玻璃体切除对合并脉络膜脱离的孔源性视网膜脱离的治疗作用。

55. Objective To outline the clinical efficacy of TongXinLuo capsule in treatment of coronary heart disease (CHD).

摘要目的观察通心络胶囊治疗冠状动脉性心脏病(CHD)的临床效果。

56. Objective: To investigate the relationship between plasma homocysteine (HCY) and insulin sensitivity in coronary heart disease (CHD).

摘要目的：瞭解冠心病患者血浆同型半胱氨酸(HCY)与胰岛素敏感性的关系。

57. Objective: To study relationship between different coronary lesions and heart rate variability (HRV) in coronary heart diease (CHD) patients.

摘要目的：探讨冠心病(CHD)患者冠状动脉不同病变程度与心率变异性(HRV)的关系。

58. Objective: To investigate the relationship among microalbuminuria (MAU), primary hypertention and coronary heart disease(CHD).

摘要目的：探讨微量白蛋白尿与原发性高血压和冠心病的关系。

59. Objective: To study the relationship between serum uric acid, bilirubin level and coronary heart disease (CHD).

摘要目的：探讨血清尿酸、胆红素水平与冠心病的关系。

60. Objective: To study the value of selective coronary angiography in patients with coronary heart disease (CHD).

摘要目的：探讨选择性冠状动脉造影在冠心病诊断及治疗中的价值。

61. Objective To investigate the relations of methionine synthase (MS) gene variation with congenital heart disease (CHD) phenotype.

摘要： 目的 ：初步探讨蛋氨酸合酶（MS）基因变异与先天性心脏病（CHD）表型的关系。

62. Methods Seventy hypercholesteremic patients with CHD evidenced by coronary angiography were selected.

摘要：目的 探讨血脂康调血脂治疗对冠心病合并高脂血症患者内皮细胞的保护作用。

63. Abstract：Objective To evaluate the risk factors and coronary angiographic characteristics of the elderly patients with CHD.

摘要：目的 观察高龄老年冠心病患者发病的危险因素与冠状动脉病变的影像学特点。

64. The sensitivity for the diagnosis of CHD was 44.29%,and the specificity was 96.88%.

斑块发生判断冠心病的敏感性为44.22%,特异性为96.88%。

65. CFM is the most useful tool which arrives at a specific diagnosis of CHD in the neonates.

新生儿先心病类型众多,临床表现复杂,CFM对所有新生儿先心病均能作出明确诊断。

66. Methods:By the standard of coronary angiography,CK-DSE was used to detect 50 cases suspected with CHD.

方法 :以冠状动脉造影 (coronaryangiography ,CAG)为标准 ,采用CK -DSE检测了 5 0例可疑CHD患者。

67. METHODS:The left ventricular function in 29 patients with CHD and 16 normal cases were detected by using of AQI DSE.

方法 :应用 AQI- DSE检测 2 9例 CHD患者和 16例正常人的左心功能变化。

68. Method:Forty patients, twenty cases with CHD(group A, n=20) and twenty cases with RHD (group B, n=20).

方法 :选择心内直视手术患者 4 0例 ,分为CHD组 (A组 ,n =2 0 ) ,RHD组 (B组 ,n =2 0 )。

69. Methods: Uricemia was detected in 60 patients with CHD and compared with that of the control group.

方法:对60例冠心病患者进行血尿酸测定,并与对照组比较。

70. Methods:The BAEP was performed on 88 patients with CHD and 35 normal subjects.

方法:对88例冠心病患者和35例正常人进行BAEP检查;

71. METHODS: Fifty patients were randomly divided into pravastatin group and control group, and 15 cases were choiced of no coronary heart disease (CHD).

方法:采用多普勒超声检测50例冠心病和15例非冠心病患者颈动脉壁斑块及血流参数,并将冠心病患者随机分为治疗组和对照组。

72. Methods:The levels of MAU were determined by enzyme linked immunosorbent assay(ELISA) in 81 primary hypertensives,66 CHD and 108 healthy controls.

方法:采用酶标记抗原一步竞争法,检测81例原发性高血压患者、66例冠心病患者及108例健康对照的尿微量白蛋白。

73. Method There were 33 men with CHD and 30 controls.CNP and ET in plasma were detected by RIA.NO in serum was detected by cadmium reduction method.

方法冠心病组男性33例、正常对照组男性30例，采用RIA测定血浆CNP和ET，镉还原法测定血清NO。

74. Methods 90 patients with CHD were randomized to either ASP 50mg/d p. o. after breakfast(group I) or to ASP 150 mg/d p.

方法将90例CHD病人,随机分为两组:I组口服ASP 50 mg/d,II组ASP 150 mg/d,早餐后顿服;

75. Methods The treatment results of xikang were compared with routine method for CHD.

方法应用欣康治疗冠心病与应用常规药对照比较治疗效果。

76. Methods 208 premenopausal women with chest pain were divided into CHD group and non CHD group according to the result of coronary angiography(CAG).

方法根据冠状动脉造影(CAG)结果,将208例绝经前女性胸痛患者分为CHD组及非CHD组,比较两组患者危险因素及三种无创检查结果的差异。

77. Methods The micro albumin in urine of30 cases of CHD patient was detected and compared with that in control group.

方法选择冠心病患者30例,检测尿中微量清蛋白含量;并设对照组进行比较。

78. Methods: The 24 h dynamic electrocardiogram monitoring was performed in 198 gerontal male CHD patients.

方法：对198例老年男性冠心病患者进行动态心电图检查。

79. Methods: The levels of MALT were determined by enzyme linked immunosorbent assay (ELISA) in 81 primary hypertensives, 66 CHD and 108 healthy controls.

方法：采用酶标记抗原一步竞争法，检测81例原发性高血压患者、66例冠心病患者及108例健康对照的尿微量白蛋白。

80. There is no differences of CD11b on neutrophils and monocytes before and after CA in patients with CHD (P>0.05).

施行CA前后CHD患者外周血PMN和单核细胞CD11b的表达没有显著性变化(P>0.05)。